PharmacovigilanceOfficial
Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
🇺🇸 FDA MedWatch · Wed 21 Oct 2026
Wedgewood Pharmacy LLC is recalling certain in-expiry compounded veterinary medications at the provider/customer level because inconsistencies were found in the reliability of analytical testing data generated by its laboratory, which could mean potency is not as labelled. The notice text provided is truncated, so the specific products, lots and any adverse events are not stated here and should be confirmed in the full FDA notice.
Official source: FDA MedWatch ↗
Summary written by VigiEye from the official notice. AI-assisted; check the source before acting.
More Pharmacovigilance
All →
Medline details repair and replace programme for recalled beds, rails, mattresses and accessories
🇺🇸 FDA MedWatch · Fri 13 Nov 2026
PRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
EMA page on veterinary signal management details phenobarbital review and updated MAH templates
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
EMA publishes draft veterinary PV guideline listing medically important VeDDRA terms
🇪🇺 EMA · Fri 13 Nov 2026
EMA opens consultation on medically important VeDDRA terms list for veterinary pharmacovigilance
🇪🇺 EMA · Fri 13 Nov 2026
FTC sues to block Covetrus's $3.5bn acquisition of veterinary distributor MWI
🇺🇸 FTC · Fri 13 Nov 2026